SupportLoginSign Up
Featured FeedJournalsCollectionsKeywords
CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Nevoid hyperkeratosis of the nipple and areola: treatment with topical retinoic acid.

G Okan, C Baykal
Journal of the European Academy of Dermatology and Venereology : JEADV 1999 November
Nevoid hyperkeratosis of the nipple and areola is a rare dermatosis with unknown etiology, (Perez-Izquierdo JM, Vilata JJ, Sanchez JL, et al. Retinoic acid treatment of nipple hyperkeratosis. Arch Dermatol 1990;126:687-688). Only 40 cases have been reported until 1997 (Alpsoy E, Yilmaz E, Aykol A. Hyperkeratosis of the nipple: report of two cases. J Dermatol 1997;24:43-45). The disease has a benign course and may only be a cosmetic problem. Different modalities have been used in the treatment of NHNA. In our case treatment with topical retinoic acid induced an acceptable response.

Full text links

Find Full Text Links for this Article

Trending Papers

Pathogenesis of autoimmune disease.David S PisetskyNature Reviews. Nephrology 2023 May 11
Arrhythmic syncope: From diagnosis to management.Jaume Francisco Pascual et al.World Journal of Cardiology 2023 April 27
The future of intensive care: the study of the microcirculation will help to guide our therapies.J Duranteau et al.Critical Care : the Official Journal of the Critical Care Forum 2023 May 17
Invasive candidiasis: current clinical challenges and unmet needs in adult populations.Alex Soriano et al.Journal of Antimicrobial Chemotherapy 2023 May 24
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association.Brian L Hoh et al.Stroke; a Journal of Cerebral Circulation 2023 May 23
Organ dysfunction and failure in liver disease.Adrià Juanola et al.Liver International : Official Journal of the International Association for the Study of the Liver 2023 May 25

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Do Not Sell My Personal InformationManage Cookie Preferences

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app